Omeros | OMER - Trade Creditors


Omeros reported $8.84M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Adma Biologics USD 22.52M 1.5M Dec/2025
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Cytokinetics USD 24.71M 80.91M Mar/2026
Gilead Sciences USD 715M 93M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Immunic USD 10.14M 2.22M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 14.01M 1.14M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Rockwell Medical USD 1.5M 423K Jun/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Xoma USD 2.65M 1.52M Sep/2025